Wealthfront Advisers LLC Biogen Inc. Transaction History

Wealthfront Advisers LLC

$29.7 Billion
Q2 2024

A detailed history of Wealthfront Advisers LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wealthfront Advisers LLC holds 3,523 shares of BIIB stock, worth $612,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,523

Previous 5,661 37.77%

Holding current value

$612,262

Previous $1.22 Million 33.11%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $407,331 - $506,107	-2,138 Reduced 37.77%	3,523 $816,000
Q1 2024 Apr 19, 2024	SELL	$212.02 - $267.71 $57,457 - $72,549	-271 Reduced 4.57%	5,661 $1.22 Million
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $73,899 - $88,956	332 Added 5.93%	5,932 $1.54 Million
Q3 2023 Nov 01, 2023	SELL	$253.3 - $285.89 $1.25 Million - $1.41 Million	-4,941 Reduced 46.87%	5,600 $1.44 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $56,426 - $65,202	205 Added 1.98%	10,541 $3 Million
Q1 2023 Apr 28, 2023	BUY	$256.56 - $292.34 $981,342 - $1.12 Million	3,825 Added 58.75%	10,336 $2.87 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $33,574 - $40,793	133 Added 2.09%	6,511 $1.8 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $363,875 - $501,751	1,869 Added 41.45%	6,378 $1.7 Million
Q2 2022 Jul 20, 2022	SELL	$187.54 - $223.02 $1.04 Million - $1.23 Million	-5,526 Reduced 55.07%	4,509 $920,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.45 Million - $1.83 Million	7,508 Added 297.11%	10,035 $2.11 Million
Q4 2021 Jan 21, 2022	SELL	$223.92 - $287.77 $1.81 Million - $2.32 Million	-8,077 Reduced 76.17%	2,527 $606,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $47,825 - $62,369	-169 Reduced 1.57%	10,604 $3 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $407,148 - $651,924	1,572 Added 17.09%	10,773 $3.73 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $697,752 - $817,457	2,872 Added 45.38%	9,201 $2.57 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $129,943 - $195,596	550 Added 9.52%	6,329 $1.55 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $570,314 - $658,499	-2,154 Reduced 27.15%	5,779 $1.64 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $510,594 - $676,193	-1,974 Reduced 19.93%	7,933 $2.12 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $340,095 - $431,415	1,265 Added 14.64%	9,907 $3.13 Million
Q4 2019 Jan 21, 2020	BUY	$220.06 - $304.07 $877,159 - $1.21 Million	3,986 Added 85.61%	8,642 $2.56 Million
Q3 2019 Oct 15, 2019	BUY	$217.44 - $243.88 $43,705 - $49,019	201 Added 4.51%	4,656 $1.08 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $582,872 - $642,491	2,658 Added 147.91%	4,455 $1.04 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $1.56 Million - $2.44 Million	-7,201 Reduced 80.03%	1,797 $425,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $2.51 Million - $3.17 Million	8,998 New	8,998 $2.71 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Biogen Inc. Transaction History